Ampersand Capital Partners Strengthens Global Operations with New London Office

Ampersand Capital Partners Expands with London Office

Ampersand Capital Partners, a respected global private equity firm specializing in growth investments within the life sciences and healthcare sectors, has announced a significant expansion of its international operations with the opening of a new office in London. This strategic move, revealed on September 3, 2025, aims to solidify Ampersand's European presence, following the successful establishment of its Amsterdam office back in 2017.

The London office will be led by Matthew Norton, who has recently joined Ampersand as a General Partner. With over 15 years of experience in healthcare private equity, Norton previously served as a Partner at Cinven, where he played a pivotal role in shaping the firm's healthcare strategy and successfully spearheading transformative growth initiatives both in Europe and the United States. His expertise in navigating the complexities of the healthcare sector will be invaluable as Ampersand seeks to identify and enhance emerging healthcare companies across the continent.

Alongside Norton, Marina Pellon-Consunji will also relocate to London. As a Partner who significantly contributed to establishing Ampersand's Amsterdam presence, she has led several strategic investments and acquisitions across Europe. Her continued efforts from the new London office are anticipated to bolster Ampersand’s operations further in the region.

Herb Hooper, the Managing Partner at Ampersand, expressed enthusiasm about these developments, stating, "We are thrilled to welcome Matthew Norton to our team and to establish a London office. With the combined experience and leadership of Matt and Marina, we are well-positioned to further our mission of identifying and scaling the next generation of global healthcare and life sciences companies."

This expansion underscores Ampersand Capital Partners' long-standing commitment to fostering exceptional growth-stage enterprises worldwide. For over three decades, the firm has focused on creating market-leading companies in the healthcare and life sciences sectors by accelerating growth across various domains, including lab products and services, contract manufacturing, and pharma services.

With its existing offices in Boston and Amsterdam, the new London presence positions Ampersand as a formidable leader in healthcare and life sciences private equity. The firm's dedication to the sector is reflected in its fruitful track record, having successfully built numerous companies that dominate their respective markets in healthcare.

Founded in 1988, Ampersand Capital Partners manages approximately $3 billion in assets, dedicating its resources to growth-oriented investments within the healthcare sector. By leveraging a unique blend of private equity knowledge and operational expertise, Ampersand aims to create long-term value alongside the management teams of its portfolio companies.

For more information on their recent initiatives and focus areas, visit Ampersand Capital Partners or follow them on LinkedIn.